Form 4: OmniAb Chief Legal Officer Charles Berkman Reports Stock Transactions
SEC Form 4 Filing
OmniAb's Chief Legal Officer, Charles Berkman, reported the vesting of restricted stock units and a subsequent sale of shares to cover tax obligations.
Summary
- Charles Berkman, Chief Legal Officer of OmniAb, Inc., reported transactions involving the company's stock.
- On December 7, 2024, 15,621 restricted stock units (RSUs) vested, converting into common stock.
- These RSUs were part of a grant that vests in three equal annual installments starting December 7, 2023.
- Following the vesting, 8,022 shares were sold on December 9, 2024, at an average price of $4.13 per share to cover tax withholding.
- The sale price ranged from $4.04 to $4.16 per share.
- After these transactions, Berkman directly owns 323,385 shares of OmniAb common stock.
Sentiment
Score: 7
Explanation: The document reflects routine insider transactions, which are neither positive nor negative for the company's overall performance. The sentiment is neutral to slightly positive due to the transparency of the filing.
Industry Context
This is a routine filing related to stock transactions by a company officer, which is common practice for publicly traded companies. It provides transparency into insider trading activity.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies in the US, and this filing is consistent with those requirements.
- The vesting of RSUs and subsequent sale to cover taxes is a common occurrence for employees of public companies, including those in the biotechnology sector like OmniAb.
- Companies like Regeneron, Amgen, and Gilead also have similar filings from their executives.
Stakeholder Impact
- The stock sale by an officer may have a minor impact on the stock price, but it is unlikely to be significant.
- The filing provides transparency to shareholders regarding insider transactions.
Key Dates
| Date | Description |
|---|---|
| 12/07/2023 | Start date for the annual vesting of the RSU grant. |
| 12/07/2024 | Date of RSU vesting and conversion to common stock. |
| 12/09/2024 | Date of stock sale to cover tax obligations. |
| 12/10/2024 | Date of the Form 4 filing. |
Keywords
OmniAb, stock transactions, restricted stock units, RSU, insider trading, Form 4, Charles Berkman, Chief Legal Officer, stock sale, tax withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.